Morgan Stanley Volitionrx LTD Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Volitionrx LTD stock. As of the latest transaction made, Morgan Stanley holds 900 shares of VNRX stock, worth $486. This represents 0.0% of its overall portfolio holdings.

Number of Shares

900

Previous 10,900 91.74%

Holding current value

$486

Previous $6,000 100.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.51 - $0.67 $5,100 - $6,700	-10,000 Reduced 91.74%	900 $0
Q4 2024 Feb 14, 2025	BUY	$0.56 - $0.88 $4,480 - $7,040	8,000 Added 275.86%	10,900 $6,000
Q3 2024 May 14, 2025	SELL	$0.5 - $0.76 $43,162 - $65,607	-86,325 Reduced 96.75%	2,900 $1,000
Q3 2024 Nov 14, 2024	SELL	$0.5 - $0.76 $43,162 - $65,607	-86,325 Reduced 96.75%	2,900 $1,000
Q2 2024 May 14, 2025	BUY	$0.59 - $0.91 $46,211 - $71,275	78,325 Added 718.58%	89,225 $54,000
Q2 2024 Oct 17, 2024	SELL	$0.59 - $0.91 $26,417 - $40,745	-44,775 Reduced 33.41%	89,225 $54,000
Q2 2024 Aug 14, 2024	SELL	$0.59 - $0.91 $26,417 - $40,745	-44,775 Reduced 33.41%	89,225 $54,000
Q1 2024 Oct 17, 2024	BUY	$0.72 - $1.19 $32,238 - $53,282	44,775 Added 50.18%	134,000 $101,000
Q1 2024 Aug 16, 2024	SELL	$0.72 - $1.19 $1,244 - $2,057	-1,729 Reduced 1.27%	134,000 $101,000
Q1 2024 May 15, 2024	SELL	$0.72 - $1.19 $1,244 - $2,057	-1,729 Reduced 1.27%	134,000 $101,000
Q4 2023 Aug 16, 2024	BUY	$0.55 - $0.88 $25,577 - $40,923	46,504 Added 52.12%	135,729 $97,000
Q4 2023 Feb 13, 2024	SELL	$0.55 - $0.88 $41,027 - $65,644	-74,596 Reduced 35.47%	135,729 $97,000
Q3 2023 Nov 15, 2023	SELL	$0.69 - $1.53 $5,437 - $12,056	-7,880 Reduced 3.61%	210,325 $145,000
Q2 2023 Aug 14, 2023	SELL	$1.39 - $2.02 $25,434 - $36,961	-18,298 Reduced 7.74%	218,205 $303,000
Q1 2023 May 15, 2023	SELL	$1.54 - $2.68 $23,705 - $41,253	-15,393 Reduced 6.11%	236,503 $451,000
Q4 2022 Feb 14, 2023	SELL	$1.39 - $2.6 $175,776 - $328,790	-126,458 Reduced 33.42%	251,896 $612,000
Q3 2022 Nov 14, 2022	SELL	$1.36 - $2.38 $25,674 - $44,929	-18,878 Reduced 4.75%	378,354 $515,000
Q2 2022 Oct 27, 2022	SELL	$1.96 - $3.05 $161,045 - $250,606	-82,166 Reduced 17.14%	397,232 $815,000
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.05 $161,045 - $250,606	-82,166 Reduced 17.14%	397,232 $815,000
Q1 2022 Oct 27, 2022	BUY	$2.41 - $3.24 $198,020 - $266,217	82,166 Added 20.68%	479,398 $1.44 Million
Q1 2022 May 13, 2022	BUY	$2.41 - $3.24 $23,726 - $31,897	9,845 Added 2.1%	479,398 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $341,127 - $466,508	-112,956 Reduced 19.39%	469,553 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$2.98 - $3.48 $1.74 Million - $2.03 Million	582,509 New	582,509 $1.81 Million

Others Institutions Holding VNRX

# of Institutions

Shares Held

21.2M

Call Options Held

Put Options Held

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $30.9M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account